You may qualify for one of our clinical trials! For more information about joining a clinical trial, please email research@
You Deserve the Best in Advanced Orthopedic Care
Clinical Trials for Orthopedic Pain
CURRENTLY RECRUITING
Discgenics - A Phase III Clinical Trial of the investigational therapy IDCT for the treatment of Lumbar Degenerative Disc Disease
This is a Phase III clinical trial of the investigational therapy IDCT (Injectable Disc Cell Therapy) for the treatment of Lumbar Degenerative Disc Disease. IDCT consists of allogeneic precursor cells that are injected into affected spinal discs to reduce chronic low back pain and improve function. This single, minimally invasive injection may offer a regenerative approach for patients who have not found relief through conservative treatments. The study involves a minimum of 8 visits over 24 months with visit compensation.
Learn more about Disc Degeneration >>
Learn more about this study >>
Learn more about this trial >>
CURRENTLY ENROLLING
CARTISTEM® - A Phase III Clinical Trial Using Donor Stem Cells for Knee Pain
This is a Phase 3 clinical trial of the investigational therapy CARTISTEM® for the treatment of Knee Osteoarthritis. CARTISTEM® uses allogeneic umbilical cord blood-derived mesenchymal stem cells to reduce knee pain and improve dysfunction caused by osteoarthritis. This procedure may offer a regenerative approach for patients who have not found relief through conservative treatments. The study involves a minimum of 9 visits over 24 months with visit compensation.
Learn more about this study >>
Learn more about this trial >>
CURRENTLY RECRUITING
ReGelTec – Pivotal Study to Evaluate the Safety and Effectiveness of the ReGelTec HYDRAFIL System in Subjects with Axial Chronic Low Back Pain (CLBP) due to Degenerative Disc Disease (DDD)
This is a pivotal study to evaluate the safety and effectiveness of HYDRAFIL-D for the treatment of Lumbar Degenerative Disc Disease. The HYDRAFIL system delivers a percutaneous hydrogel spinal implant (the HYDRAFIL implant) for nucleus pulposus augmentation. The implant is injected into affected spinal discs to reduce chronic low back pain and improve function. This single, minimally invasive injection may offer a regenerative approach for patients who have not found relief through conservative treatments. The study involves a minimum of 7 visits over 24 months with visit compensation.
Learn more about Disc Degeneration >>
Learn more about this study >>
Learn more about this Pivotal study >>
CURRENTLY RECRUITING
VIVEX - A Clinical Trial Using Donor Nucleus Pulposus Tissue for Low Back Pain
This is a clinical trial of the investigational therapy VIA Disc NP for the treatment of Lumbar Degenerative Disc Disease. VIA Disc NP uses donor cadaveric nucleus pulposus tissue processed and injected into affected spinal discs to reduce chronic low back pain and improve function. This single, minimally invasive injection may offer a regenerative approach for patients who have not found relief through conservative treatments. The study involves a minimum of 6 visits over 24 months with visit compensation.
Learn more about Disc Degeneration >>
Learn more about this study >>
Learn more about this trial >>
